News > Reasons young women stop taking tamoxifen vary over time

Reasons young women stop taking tamoxifen vary over time

general_content

Looking at a little understood yet common phenomenon—women discontinuing tamoxifen therapy early—French researchers found several factors caused women to interrupt treatment. These factors varied, depending upon when the women stopped therapy.

The study was published in the Annals of Oncology.

Background and reason for the study

Tamoxifen is a medicine used to treat hormone receptor-positive breast cancer, often in premenopausal women. It is given after primary treatments such as surgery and chemotherapy.

Tamoxifen prevents the return of breast cancer by blocking estrogen from reaching estrogen receptors. The standard recommendation is to take tamoxifen for five years, although a major new study now suggests that giving it for 10 years increases benefits.

Although tamoxifen is effective, many women stop taking it before they finish the full treatment course. Some may stop because of common side effects, such as hot flashes, vaginal dryness and mood swings. Others may worry about tamoxifen’s rare side effects, including blood clots and increased risk of uterine cancer. Some women might stop in order to become pregnant, since tamoxifen can damage a fetus.

Other factors also might cause women to stop treatment. The researchers wanted to find out how often young women discontinue tamoxifen and to identify the reasons why.

Study structure

The study looked at 196 women from southeastern France who were 18 to 40 years old at diagnosis. The women, diagnosed from 2005 to 2008, were part of a larger group being studied to learn about their post-treatment lives.

Using pharmacy refill data, the researchers measured how often women stopped tamoxifen treatment. An interruption was defined as two or more consecutive months without dispensed tamoxifen prescriptions.

To determine when the women discontinued tamoxifen, the researchers looked at two time periods:

  • From the start of taking tamoxifen to 16 months after diagnosis
  • From 16 months to 28 months post-diagnosis

Reasons for stopping tamoxifen were organized according to the treatment time period.

Findings

Within the first two years of treatment, 42 percent of the young women stopped taking tamoxifen.

In the first time period (up to 16 months after diagnosis), interruptions were associated with:

  • Lack of information the women could understand about tamoxifen
  • Not enough social support

For the second time period (16 to 28 months after diagnosis), interruptions were associated with:

  • Side effects
  • No longer being afraid of breast cancer returning
  • Lack of social support
  • Not being able to ask questions at diagnosis
  • Fewer types of treatment

The researchers concluded that better communications between women and providers and improved information might help prevent discontinuation of tamoxifen. They also advised healthcare providers to give more attention to women who have little social support.

What this means for you

It can be difficult to think about taking a medicine every day for five or 10 years, especially if you have side effects. Yet tamoxifen can be a key part of your continuing care and staying on it helps prevent a breast cancer recurrence.

If you are having trouble taking tamoxifen, or are thinking about stopping for any reason, talk with your healthcare team before discontinuing. They can offer ways to lessen or eliminate side effects. They also understand the emotional concerns you may be facing.

Your oncologist can answer questions you may have about using tamoxifen or wanting to become pregnant. Your oncology nurse may have suggestions for dealing with side effects and ways to stay on medicine important for avoiding a breast cancer return. You might also find it helpful to talk with an oncology social worker or counselor.

C Cluze, D Rey, L Huiart et al. Adjuvant Endocrine Therapy with Tamoxifen in Young Women with Breast Cancer: Determinants of Interruptions Vary Over TimeAnnals of Oncology, 2012; 23(4):882-890.

disclaimer_box

This article was supported by Cooperative Agreement Number DP11-1111 from The Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.

related_resources_article_carousel

Related resources

Related articles and posts

Early menopause

8/26/22 | BY: Ann Honebrink

If you are premenopausal or perimenopausal, breast cancer treatments — including surgery to remove ovaries, chemotherapy, and hormonal therapy — may cause your menstrual periods to stop for a while or, in some cases, permanently.

Read More | 9 Min. Read

Menopausal symptoms

8/12/22 | BY: Anne Katz

Some treatments can cause temporary menopause, and others can cause permanent menopause. Even if you went through menopause naturally before treatment, treatment can sometimes bring new symptoms, or changes in how you've experienced symptoms.

Read More | 10 Min. Read

Young Women

5/04/22 | BY: Don Dizon

If you’re a woman diagnosed with breast cancer before the age of 45, your medical and emotional concerns may be very different than those of women who are diagnosed when they are older. Body image, relationships, career, intimacy, fertility, and parenting are just some of the issues and life areas that can bring up questions for you.

Read More |

Talking with your partner about sex

8/13/20 | BY: Don Dizon, Michael Krychman, Anne Katz, Helen Coons, Sabitha Pillai-Friedman, Susan Kellogg-Spadt

Breast cancer can have physical and emotional impacts on your sexual life. Communication is key to keeping relationships strong, but it’s not always easy to start a conversation about sex. Here our community offers some tips to get the dialogue started.

Read More | 6 Min. Read

Ovarian suppression

11/05/19

Ovarian suppression is surgery, radiation therapy or medicine that is used in premenopausal women to stop the ovaries from working.

Read More | 4 Min. Read

If you feel pain during sex

11/04/19 | BY: Don Dizon

Breast cancer treatment can cause side effects that affect your sexual life, including pain during intercourse or penetration. If this is happening, it’s very important to talk with your healthcare provider.

Read More | 5 Min. Read

Types of hormonal therapy

11/04/19 | BY: Jennifer Winn

Hormonal therapy medicines are put into classes based on how they interact with the body’s natural hormones estrogen and progesterone. Some stop the body from making estrogen, while others prevent estrogen from helping the cancer cell grow.

Read More | 6 Min. Read

Tamoxifen

11/04/19 | BY: Jennifer Winn

Tamoxifen is a type of hormonal therapy called a SERM, or selective estrogen receptor modulator, a medicine that prevents estrogen signals from getting to breast cancer cells.

Read More | 6 Min. Read

Gonadotropin releasing hormone (GnRH) agonists

10/07/19 | BY: H. Irene Su

The gonadotropin releasing hormone agonists, or GnRH agonists, are a class of injectable medicines offered to pre- and perimenopausal women with breast cancer in order to temporarily suppress, or slow, ovarian function.

Read More | 5 Min. Read

Making decisions about protecting your fertility

9/06/19 | BY: H. Irene Su

You might not be thinking about having a family at the time of your diagnosis, but that’s the best time to talk with your partner, family, and healthcare team about future fertility.

Read More | 6 Min. Read
3_callout_columns